Literature DB >> 21613644

Divergent trends for gastric cancer incidence by anatomical subsite in US adults.

M Constanza Camargo1, William F Anderson, Jessica B King, Pelayo Correa, Cheryll C Thomas, Philip S Rosenberg, Christie R Eheman, Charles S Rabkin.   

Abstract

BACKGROUND AND AIM: Age-specific analyses of non-cardia gastric cancer incidence reveal divergent trends among US whites: rates are declining in individuals aged 40 years and older but rising in younger persons. To investigate this heterogeneity further, incidence trends were evaluated by anatomical subsite.
METHODS: Gastric cancer incidence data for 1976-2007 were obtained from the US National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program and the US Centers for Disease Control and Prevention's National Program of Cancer Registries (NPCR). Incidence rates and estimated annual percentage change were calculated by age group (25-39, 40-59 and 60-84 years), race/ethnicity and subsite.
RESULTS: Based on data from the nine oldest SEER registries (covering ~10% of the US population), rates for all non-cardia subsites decreased in whites and blacks, except for corpus cancer, which increased between 1976 and 2007 with estimated annual percentage changes of 1.0% (95% CI 0.1% to 1.9%) for whites and 3.5% (95% CI 1.8% to 5.2%) for blacks. In contrast, rates for all non-cardia subsites including corpus cancer declined among other races. In combined data from NPCR and SEER registries (covering 89% of the US population), corpus cancer significantly increased between 1999 and 2007 among younger and middle-aged whites; in ethnic-specific analyses, rates significantly increased among the same age groups in non-Hispanic whites and were stable among Hispanic whites. Age-specific rates for all subsites declined or were stable in this period among blacks and other races.
CONCLUSIONS: Long- and short-term incidence trends for gastric cancers indicate a shifting distribution by anatomical subsite. Corpus cancer may have distinctive aetiology and changing risk factor exposures, warranting further investigation.

Entities:  

Mesh:

Year:  2011        PMID: 21613644      PMCID: PMC3202077          DOI: 10.1136/gut.2010.236737

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  45 in total

1.  Proton pump inhibitors and gastric neoplasia.

Authors:  E J Kuipers
Journal:  Gut       Date:  2006-09       Impact factor: 23.059

2.  Have Americans increased their fruit and vegetable intake? The trends between 1988 and 2002.

Authors:  Sarah Stark Casagrande; Youfa Wang; Cheryl Anderson; Tiffany L Gary
Journal:  Am J Prev Med       Date:  2007-04       Impact factor: 5.043

3.  Association of Epstein-Barr virus antibody levels with precancerous gastric lesions in a high-risk cohort.

Authors:  Aaron J Schetter; Wei-cheng You; Evelyne T Lennette; Mitchell T Gail; Charles S Rabkin
Journal:  Cancer Sci       Date:  2008-01-14       Impact factor: 6.716

Review 4.  Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma.

Authors:  Masashi Fukayama; Rumi Hino; Hiroshi Uozaki
Journal:  Cancer Sci       Date:  2008-07-04       Impact factor: 6.716

Review 5.  Smoking and gastric cancer: systematic review and meta-analysis of cohort studies.

Authors:  Ricardo Ladeiras-Lopes; Alexandre Kirchhofer Pereira; Amanda Nogueira; Tiago Pinheiro-Torres; Isabel Pinto; Ricardo Santos-Pereira; Nuno Lunet
Journal:  Cancer Causes Control       Date:  2008-02-22       Impact factor: 2.506

Review 6.  Epstein-Barr virus associated gastric carcinoma: epidemiological and clinicopathological features.

Authors:  Suminori Akiba; Chihaya Koriyama; Roberto Herrera-Goepfert; Yoshito Eizuru
Journal:  Cancer Sci       Date:  2008-02       Impact factor: 6.716

Review 7.  Smoking increases the treatment failure for Helicobacter pylori eradication.

Authors:  Takeshi Suzuki; Keitaro Matsuo; Hidemi Ito; Akira Sawaki; Kaoru Hirose; Kenji Wakai; Shigeki Sato; Tsuneya Nakamura; Kenji Yamao; Ryuzo Ueda; Kazuo Tajima
Journal:  Am J Med       Date:  2006-03       Impact factor: 4.965

8.  Persistent oxidative stress in the corpus mucosa is evoked by long-term treatment of H. pylori-infected patients with proton pump inhibitors.

Authors:  Masayuki Suzuki; Shin Tanaka; Koichi Suzuki; Tetsuji Kitahora; Tatsuhiro Masaoka; Hidekazu Suzuki; Toshifumi Hibi
Journal:  Hepatogastroenterology       Date:  2008 Jan-Feb

9.  Effect of smoking on failure of H. pylori therapy and gastric histology in a high gastric cancer risk area of Colombia.

Authors:  M Constanza Camargo; M Blanca Piazuelo; Robertino M Mera; Elizabeth T H Fontham; Alberto G Delgado; M Clara Yepez; Cristina Ceron; Luis E Bravo; Juan C Bravo; Pelayo Correa
Journal:  Acta Gastroenterol Latinoam       Date:  2007-12

10.  Trends in fruit and vegetable consumption among U.S. men and women, 1994-2005.

Authors:  Heidi Michels Blanck; Cathleen Gillespie; Joel E Kimmons; Jennifer D Seymour; Mary K Serdula
Journal:  Prev Chronic Dis       Date:  2008-03-15       Impact factor: 2.830

View more
  49 in total

Review 1.  Inhibition of Hedgehog signaling in the gastrointestinal tract: targeting the cancer microenvironment.

Authors:  Juanita L Merchant; Milena Saqui-Salces
Journal:  Cancer Treat Rev       Date:  2013-08-13       Impact factor: 12.111

2.  Racial/Ethnic Patterns of Young-Onset Noncardia Gastric Cancer.

Authors:  Andreana N Holowatyj; Cornelia M Ulrich; Mark A Lewis
Journal:  Cancer Prev Res (Phila)       Date:  2019-08-16

3.  Height, weight, and body mass index associations with gastric cancer subsites.

Authors:  M Constanza Camargo; Neal D Freedman; Albert R Hollenbeck; Christian C Abnet; Charles S Rabkin
Journal:  Gastric Cancer       Date:  2013-10-31       Impact factor: 7.370

Review 4.  Changing Trends in Stomach Cancer Throughout the World.

Authors:  Maya Balakrishnan; Rollin George; Ashish Sharma; David Y Graham
Journal:  Curr Gastroenterol Rep       Date:  2017-08

5.  Familial gastric cancer: guidelines for diagnosis, treatment and periodic surveillance.

Authors:  Irma Kluijt; Rolf H Sijmons; Nicoline Hoogerbrugge; John T Plukker; Daphne de Jong; J Han van Krieken; Richard van Hillegersberg; Marjolijn Ligtenberg; Eveline Bleiker; Anemieke Cats
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

Review 6.  Treatment of early gastric cancer in the Western World.

Authors:  Elfriede Bollschweiler; Felix Berlth; Christoph Baltin; Stefan Mönig; Arnulf H Hölscher
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

7.  CD133 Expression as a Helicobacter pylori-independent Biomarker of Gastric Cancer Progression.

Authors:  Rachel Howard; Sameer Al Diffalha; Jose Pimiento; Jaime Mejia; Heiko Enderling; Anna Giuliano; Domenico Coppola
Journal:  Anticancer Res       Date:  2018-08       Impact factor: 2.480

8.  An Investigation into the Recent Increase in Gastric Cancer in the USA.

Authors:  Maya Balakrishnan; Rollin George; Ashish Sharma; David Y Graham; Hoda M Malaty
Journal:  Dig Dis Sci       Date:  2018-03-15       Impact factor: 3.199

Review 9.  Recapitulating Human Gastric Cancer Pathogenesis: Experimental Models of Gastric Cancer.

Authors:  Lin Ding; Mohamad El Zaatari; Juanita L Merchant
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

10.  Age and sex interactions in gastric cancer incidence and mortality trends in Korea.

Authors:  Minkyo Song; Daehee Kang; Jae Jeong Yang; Ji-Yeob Choi; Hyuna Sung; Yunhee Lee; Hyung-Suk Yoon; Yunhee Choi; Seong-Ho Kong; Hyuk-Joon Lee; Han-Kwang Yang; Woo Ho Kim
Journal:  Gastric Cancer       Date:  2014-08-05       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.